Login / Signup

IDH1/2 inhibitor monotherapy in blast-phase myeloproliferative neoplasms: A multicentre experience.

Naseema GangatHelen AjufoMaymona AbdelmagidOmer KarrarKristen McCulloughTalha BadarJames M ForanJeanne PalmerHassan B AlkhateebAbhishek A MangaonkarAndrew T KuykendallRaajit K RampalAyalew Tefferi
Published in: British journal of haematology (2023)
Keyphrases
  • combination therapy
  • low grade
  • study protocol
  • clinical trial
  • open label
  • double blind
  • cross sectional
  • wild type
  • randomized controlled trial
  • high grade